Transcatheter aortic valve replacement in failed surgical valves.
bicuspid aortic valve
transcatheter valve interventions
Journal
Heart (British Cardiac Society)
ISSN: 1468-201X
Titre abrégé: Heart
Pays: England
ID NLM: 9602087
Informations de publication
Date de publication:
03 2019
03 2019
Historique:
received:
12
11
2018
revised:
22
11
2018
accepted:
28
11
2018
entrez:
9
3
2019
pubmed:
9
3
2019
medline:
23
6
2020
Statut:
ppublish
Résumé
Aortic valve-in-valve is a less invasive alternative to surgical redo in the treatment of failed bioprosthetic valves. While only inoperable patients underwent the procedure before, operators currently offer it to those at lower risk and worldwide experience is in the thousands. Early mortality has diminished in recent analyses and improvements in symptoms and quality of life have been documented. Main considerations with aortic valve-in-valve include elevated postprocedural gradients, coronary obstruction and leaflet thrombosis. Risk factors for each of these adverse events have been described at length. Aortic valve-in-valve offers a safe and effective option in the management of failed bioprosthetic valves.
Identifiants
pubmed: 30846524
pii: heartjnl-2018-313517
doi: 10.1136/heartjnl-2018-313517
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
s38-s43Informations de copyright
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.